New Landscapes on the Road of Open Science: 6 key issues to address for research data management in the Netherlands | Open Working

“The road to Open Science is not a short one. As the chairman of the Executive Board of the European Open Science Cloud, Karel Luyben, is keen to point out, it will take at least 10 or 15 years of travel until we reach a point where Open Science is simply absorbed into ordinary, everyday science.

Within the Netherlands, and for research data in particular, we have made many strides towards that final point. We have knowledge networks such as LCRDM, a suite of archives covered by the Research Data Netherlands umbrella, and the groundbreaking work done by the Dutch Techcentre for Life Sciences.

But there is still much travel to be done; many new landscapes to be traversed. Data sharing is still far from being the norm (see here for a visualisation of these results).

The authors of this blog post have put together six areas that, in their opinion, deserve attention on our Open Science journey….”

The OpenAIRE Research Graph – OpenAIRE Blog

“The backdrop: Open Science is gradually becoming the modus operandi in research practices, affecting the way researchers collaborate and publish, discover, and access scientific knowledge. Scientists are increasingly publishing research results beyond the article, to share all scientific products (metadata and files) generated during an experiment, such as datasets, software, experiments. They publish in scholarly communication data sources (e.g. institutional repositories, data archives, software repositories), rely where possible on persistent identifiers (e.g. DOI, ORCID, Grid.ac, PDBs), specify semantic links to other research products (e.g. supplementedBy, citedBy, versionOf), and possibly to projects and/or relative funders. By following such practices, scientists are implicitly constructing the Global Open Science Graph, where by “graph” we mean a collection of objects interlinked by semantic relationships.”

SPARC Europe releases summary of Open Data Directive and guidance for its implementation – SPARC Europe

“In July of this year, The Directive on open data and the re-use of public sector information, also called the “Open Data Directive” went into effect. To aid in the implementation of this new legislation, of which members states have until 16 July 2021 to transpose, SPARC Europe today is releasing a summary coupled with implementation guidance. It is important that in each country, there are people willing to help represent the interests of open access to research data by helping influence policy-makers to implement this directive effectively. This can be accomplished more effectively by colleagues teaming up with one another on a country basis. This document should be of use in this effort.

This policymaking for Open Science was a collaborative effort between the Digital Curation Centre (DCC), EBLIDA, IFLA, LIBER, and SPARC Europe, with SPARC Europe as co-ordinator. We hope this guidance will prove useful to academic libraries in Europe when implementing this into national legislation.

The Directive is the result of an effort to provide a common legal framework for public sector information in the EU; a framework that reflects the evolution of digital technologies and encompasses materials held by public sector bodies in the Member States, from a national to a local level. Research institutions, libraries and archives are within the directive’s scope. 

As written in our summary: “… the Directive takes positive steps to enhance the way that publicly-funded research data is made available, accessed, shared and re-used. Member States are required to develop national policies for open access to research data resulting from public funding, following the principle of ‘open by default’, while new harmonised rules on re-usability are to be applied to all publicly-funded research data which is already made accessible via open repositories.”…”

MoRRI – Monitoring the Evolution and Benefits of Responsible Research and Innovation – Technopolis Group

“MoRRI’s main objective is “to provide scientific evidence, data, analysis and policy intelligence to support directly Directorate General for Research and Innovation (DG-RTD) research funding activities and policy-making activities in relation with Responsible Research and Innovation (RRI)”.

RRI is a concept that is recently gaining momentum but it still lacks agreement on its definition, content and details. Hence, part of this study is to determine the scope and the benefits or RRI for Europe by:

Operationalising the concept;
Developing a sound conceptual framework and associated methodology, while at the same time;
Testing the potential of this methodology to allow monitoring the current state and short-term evolution of Responsible Research and Innovation and its socio-economic and democratic impacts….”

Canada Opens the Door to Public Scrutiny of Clinical Drug Trials

“This past March, Canada’s department of health changed the way it handles the huge amount of data that companies submit when seeking approval for a new drug, biological treatment, or medical device — or a new use for an existing one. For the first time, Health Canada is making large chunks of this information publicly available after it approves or rejects applications.

Within 120 days of a decision, Health Canada will post clinical study reports on a new government online portal, starting with drugs that contain novel active ingredients and adding devices and other drugs over a four-year phase-in period. These company-generated documents, often running more than 1,000 pages, summarize the methods, goals, and results of clinical trials, which test the safety and efficacy of promising medical interventions. The reports play an important role in helping regulators make their decisions, along with other information, such as raw data about individual patients in clinical trials.

So far, Health Canada has posted reports for four newly approved drugs — one to treat plaque psoriasis in adults, two to treat two different types of skin cancer, and the fourth for advanced hormone-related breast cancer — and is preparing to release reports for another 13 drugs and three medical devices approved or rejected since March.

Canada’s move follows a similar policy enacted four years ago by the European Medicines Agency (EMA) of the European Union. The U.S. Food and Drug Administration (FDA), on the other hand, continues to treat this information as confidential to companies and rarely makes it public….”

Decrypting the Big Deal Landscape: Follow-up of the 2019 EUA Big Deals Survey Report

“As of 2017, the European University Association (EUA) assembled a unique collection of ‘Big Deals’ data on agreements between scholarly publishers and (national) consortia of libraries, universities and research organisations. This was carried out in the light of mounting higher education institution concerns about the increasingly unsustainable cost of subscriptions to scholarly publications. In 2016, EUA committed to “establishing an evidence base about current agreements and on-going negotiations with publishers in collaboration with NRCs”.1 Subsequently, data collected by EUA has served as the basis for two reports released in 2018 and 2019, respectively.2 Big Deals now receive increased attention due to their potential to ‘flip’ entire segments of the scholarly publication market from closed to open access publications. Big deals have also been widely criticised for locking-in library budgets, due to constantly increasing subscription costs. The 2019 EUA Big Deals Survey Report surveyed covered 30 European countries and found that over €1 billion is spent on electronic resources each year, including at least €726 million spent on periodicals alone. Big Deals are said to limit competition and innovation in the scholarly publishing system3 and curb universities’ and consortia’s financial freedom to pursue other priorities. However, recently, several European negotiating consortia and scholarly publishers have concluded Big Deals that allow eligible authors to publish articles in open access formats in specific journals. Known as ‘transformative agreements’, these contracts are also supported as one way to comply with future funder requirements that will apply as of 2021 under Plan S.4 In a system that is largely defined by Big Deals, this report aims to inform the transition to open access debate, by providing additional insights and indicators on these agreements’ costs, publication volumes and timelines. This has been achieved by placing EUA Big Deals data into context….

Part 1 explains the methods used to obtain the underlying data as well as limitations and responsible use of the data. Part 2 links the publication outputs of journal articles and reviews to the large five publishers’ market share. It seeks to provide a bigger picture of the relation between subscription costs and publishing output. Part 3 sets out an analysis of the price-per-article for each country and publisher, calculated on the basis of subscription prices and publication volume. It provides European negotiators with comparative Big Deals price per article data in 26 countries. Part 4 takes a closer look at the timeline of Big Deal agreements collected by the EUA Big Deals Survey. It shows that the 2018-2020 period is crucial for negotiations with scholarly publishers (in terms of market volume). Negotiations that occur during this time may also be crucial for the further development of ‘transformative’ agreements and therefore compliance with Plan S requirements. Part 5 provides a brief summary of our main findings, contextualises them with current developments and provides policy recommendations….”

Decrypting the Big Deal Landscape: Follow-up of the 2019 EUA Big Deals Survey Report | EUA

by Lennart Stoy, Rita Morais and Lidia Borrell-Damián

Based on the data collected for the 2019 Big Deals Survey Report, this publication aims to deliver additional transparency of the dynamics of the scholarly publishing market by providing insights and indicators on the costs, publication volumes and timelines of Big Deal contracts. The report is part of EUA’s support to universities and consortia striving to create a transparent and sustainable open access publishing system, in particular in the context of Plan S.

This has been achieved by placing EUA Big Deals data into context. Specifically, this report uses aggregate data obtained from the Web of Science by Clarivate Analytics provided by the German Competence Center for Bibliometrics and correlates it with EUA data on Big Deals. The report uses data from 26 countries and contracts with the publishers Elsevier, Springer Nature, Taylor & Francis, Wiley and American Chemical Society collected in late 2018.

Research Assessment in the Transition to Open Science

“This report provides a comprehensive and up-to-date overview of the current state of research assessment at European universities, and shows why and how institutions are reviewing their evaluation practices. Based on the results of the 2019 EUA Open Science and Open Access Survey on Research Assessment, it aims to inform and strengthen the discussion by gathering and sharing information about current and future university approaches to research assessment….”

No borders on knowledge? WIPO debates key question | EIFL

“EIFL will join copyright experts, librarians, educators and government representatives in Geneva to debate a key question facing libraries, archives and museums today: will copyright barriers to accessing knowledge be removed?…

In developing countries, where easy access to knowledge is critical for education and socio-economic development, the situation is particularly acute. For example, out of 53 countries surveyed in Africa in the WIPO study by Professor Kenneth Crews, 13 countries have no exception for libraries, only one country allows inter-library document delivery, and no countries permit cross-border exchange. …”

 

Achieving Open Science in the European Open Science Cloud. Setting out OpenAIRE’s vision and contribution to EOSC – Executive Summary | Zenodo

“Key to EOSC architecture is its sustainability, which will primarily be driven by: 1- a participatory design and governance to accommodate different needs and requirements, 2- shared investments as they are being developed by member states (MS/AC), 3- the ability to adapt to new technologies and foster innovation. It is therefore critical that EOSC architecture avoids at any cost a monolithic and centralized approach, and follow a “System of Systems” approach, where resources are brought together at different levels to deliver data and data services. Emphasis is therefore placed on a business-tobusiness (B2B) sharing (data, services, people) and access, with agreements on: 1- A shared policy compliance framework (i) dictating and applying the rules of how the data elements are published, shared and re-used, and (ii) implementing an interlinked data space where every research result comes with its context (related entities), provenance (full data and science path) and usage….

EOSC will converge national support structures bringing all players together in a collaborative arrangement. No single organization is able to fulfil the Commons approach alone and implementation of Open Science requires specific handling, as most of the barriers are cultural and organizational….

For Open Science to succeed in EOSC, we need to: i) provide services for all stakeholders involved in the research life cycle, ii) ensure data federation for both small and big data to become an integral part of EOSC, iii) embed services in institutional settings, and iv) link to international infrastructures. …”